JPRN-jRCTs031180291进行中（未招募）未知
Preoperative chemoradiotherapy with irinotecan and S-1 for locally advanced rectal cancer - Preoperative IRIS
eno Hideki0 个研究点目标入组 50 人开始时间: 2019年3月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •(1) Rectal or anal cancer whose lower tumor margin is below the peritoneal reflection. The clinical stage is II or III.
- •(2) Histologically confirmed adenocarcinoma
- •(3) Without prior anti-tumor therapy
- •(4) Age:20-80years old
- •(5) Performance status 0-2
- •(6) Adequate organ function
- •WBC>= 4,000 <= 15,000/mm3
- •neutro>= 2,000/mm3
- •Plt>= 100,000/mm3
- •Hb>= 8.0g/dl
- •Cr<= 1.5mg/dl
- •T-Bil<= 1.5mg/dl
- •AST, ALT<= double of the upper limit
- •(7) Written IC with date
排除标准
- •(1) Severe diabetes
- •(2) Severe hypertension
- •(3) Interstitial pneumonitis, pulmonary fibrosis, severe pulmonary emphysema
- •(4) Active chronic hepatitis B or C
- •(5) Blood Transfusion within the last 2 weeks
- •(6) Patients with mental diseases judged inappropriate for this study by the physicians
- •(7) Without written IC with date
- •(8) Contraindication for taking CPT-11
- •(9) Contraindication for taking S-1
- •(10) Patients judged inappropriate for this study by the physicians
研究者
相似试验
已完成
不适用
Preoperative chemoradiotherapy with irinotecan and S-1 for locally advanced rectal cancerJPRN-UMIN000011993ational Defense Medical College49
已完成
不适用
Preoperative chemoradiotherapy with irinotecan and S-1 for locally advanced rectal cancerocally advanced rectal cancer Locally advanced anal cancerJPRN-UMIN000026306ational Defense Medical College50
已完成
不适用
A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervixstage 1b2/2 cervical cancerJPRN-UMIN000000552Japanese Gynecologic Oncology Group65
进行中（未招募）
不适用
Preoperative combined radiochemotherapy for patients with newly diagnosed, primary operable and locally advanced rectal carcinoma (cT3, Nx, M0) of the lower and middle rectum - Studie R02 (95)ocally advanced rectal carcinoma (cT3, Nx, M0) of the lower and middle rectum.EUCTR2004-002358-72-ATAustrian Breast and Colorectal Cancer Study Group (ABCSG)60
已完成
1 期
Preoperative chemoradiation therapy combined with peptide vaccination for T3-pancreatic cancer: prospective phase I/II studyT3(UICC)-pancreatic cancerJPRN-UMIN000004422Department of Gastroenterological Surgery, Osaka Medical Center for cancer & Cardiovascular Diseases50